Stock A348150 KOBIOLABS, INC
Add to a list
To use this feature you must be a member
Log inSign up

Financials KoBioLabs, Inc

Equities

A348150

KR7348150004

Food Processing

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 20/05/2024 BST 		5-day change 1st Jan Change
7,870 KRW +1.03% Intraday chart for KoBioLabs, Inc +2.34% -7.52%
2022 5,607,000 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-NOV-2022. CI
2022 KoBioLabs, Inc announced that it has received KRW 10.000016 billion in funding from E-MART Inc. CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 672,727 335,174 191,231 160,602
Enterprise Value (EV) 1 621,839 255,686 112,066 112,656
P/E ratio -8.44 x -21.5 x -8.47 x -11.4 x
Yield - - - -
Capitalization / Revenue 147 x 116 x 16.5 x 4.85 x
EV / Revenue 135 x 88.4 x 9.66 x 3.4 x
EV / EBITDA -51.2 x -15.9 x -5.78 x -6.65 x
EV / FCF -6.86 x -16 x -4.56 x -5.4 x
FCF Yield -14.6% -6.26% -21.9% -18.5%
Price to Book 12.1 x 3.74 x 2.52 x 3.59 x
Nbr of stocks (in thousands) 15,519 16,271 17,306 18,872
Reference price 2 43,350 20,600 11,050 8,510
Announcement Date 23/03/21 15/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales 1 4,591 2,893 11,606 33,138
EBITDA 1 -12,135 -16,105 -19,383 -16,943
EBIT 1 -12,345 -16,337 -20,292 -18,458
Operating Margin -268.87% -564.66% -174.84% -55.7%
Earnings before Tax (EBT) 1 -55,072 -16,368 -23,030 -14,683
Net income 1 -55,072 -15,382 -21,921 -13,853
Net margin -1,199.45% -531.63% -188.89% -41.8%
EPS 2 -5,138 -959.0 -1,305 -747.7
Free Cash Flow 1 -90,604 -16,000 -24,552 -20,874
FCF margin -1,973.31% -552.99% -211.56% -62.99%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 23/03/21 15/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 - - - -
Net Cash position 1 50,889 79,488 79,165 47,946
Leverage (Debt/EBITDA) - - - -
Free Cash Flow 1 -90,604 -16,000 -24,552 -20,874
ROE (net income / shareholders' equity) -1,173% -21.1% -25.1% -19.3%
ROA (Net income/ Total Assets) -16.4% -12.5% -11.1% -9.67%
Assets 1 334,972 123,394 198,102 143,228
Book Value Per Share 2 3,569 5,514 4,391 2,369
Cash Flow per Share 2 2,618 3,239 598.0 532.0
Capex 1 125 5,512 14,683 15,133
Capex / Sales 2.72% 190.52% 126.52% 45.67%
Announcement Date 23/03/21 15/03/22 21/03/23 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
KOBIOLABS, INC Stock KoBioLabs, Inc
-7.52% 109M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+17.57% 8.47B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+3.37% 7.6B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+5.65% 6.26B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-4.57% 3.78B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-2.14% 1.35B
HERBALIFE LTD. Stock Herbalife Ltd.
-26.41% 1.12B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+15.61% 998M
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-7.15% 948M
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
-16.17% 808M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. A348150 Stock
  4. Financials KoBioLabs, Inc